Generic selectors
Exact matches only
Search in title
Search in content
Filter by Categories
Deals
Features
News
Region
Sectors
Size

Exit

Prenetics tests out $1.25bn reverse merger
Genetic testing services provider Prenetics, a spinout of City University of Hong Kong, will hold a reverse merger at a $1.25bn valuation.
Context Therapeutics frames IPO plans
Based on research at Drexel University, Context Therapeutics is seeking to raise up to $21m in an initial public offering on Nasdaq.
Exscientia explores Nasdaq IPO
Dundee spinout Exscientia is continuing a busy fundraising year with a filing for an IPO in the US and a $35m concurrent private placement.
Stryker gets Gauss Surgical in acquisition
Stryker has bought the surgery monitoring software provider, which was backed by Stanford-StartX Fund.
Ally Therapeutics shuts down
The Harvard spinout had raised $10m in seed funding from investors including Arch Venture Partners, but disappointing animal studies led the company to be wound down.
Satalia says yes to WPP offer
WPP has acquired UCL spinout Satalia for an undisclosed amount, almost 13 years after being founded.
Stellatus snapped up by Slingshot Aerospace
Slingshot Aerospace has acquired the UChicago spinout developing a communication channel for preventing satellite collisions in space.
Rigaku embraces MILabs acquisition
TU Delft and UMC Utrecht spinout MILabs has been purchased by Rigaku Corporation, which plans to use its medical imaging technology in drug development.

Other News

SGS says yes to Mitsubishi Electric
Strathclyde spinout Smarter Grid Solutions has been bought by Mitsubishi Electric for an undisclosed figure.
Evonik executes JeNaCell acquisition
Evonik has bought one of its existing portfolio companies, Friedrich Schiller University Jena spinout JeNaCell, for an undisclosed sum.
Icosavax lands on $182m IPO
UW's vaccine development company has listed on Nasdaq, with its shares rising on the first day of trading.
Tenaya tends to $180m IPO
The GV-backed cardiovascular therapeutics company has priced an upsized offering on Nasdaq, with the shares closing just marginally higher on the first day.
Tepha ticks acquisition box
Based on research originally conducted at MIT, Tepha has been purchased by BD for an undisclosed sum.
DataRobot processes Algorithmia acquisition
OUP has exited Algorithmia following its acquisition by DataRobot for an undisclosed sum.

Editor's Picks

Aerovate accesses public markets
Less than a year after raising $72.6m in its series A round, Aerovate Therapeutics has gone public following an IPO worth more than $121m.
Otsuka takes up Veryan’s acquisition offer
ICL vascular implant spinout Veryan Medical has been bought by medical device firm Otsuka after raising $56m from investors including IP Group.
Big deal: Orchard harvests $200m IPO
Orchard Therapeutics has listed in the US following a $200m initial public offering that came just three years after the gene therapy developer was spun out of UCL.
Big deal: Novo pens $800m Ziylo acquisition
Ziylo, a spinout from University of Bristol that is working on a diabetes treatment, has been acquired by Novo Nordisk for a total that could exceed $800m.
test reg

Login